Law360, New York (September 23, 2009, 7:41 PM ET) -- AstraZeneca Pharmaceuticals LP has lost an appeal of a $12.9 million decision in litigation over average wholesale drug prices and earned a fresh rebuke from the appeals court for its “unfair and deceptive” pricing policies.
Responding to a “panoply of challenges” by AstraZeneca, the U.S. Court of Appeals for the First Circuit found that the trial court ruled without committing material legal error, abusing its discretionary power or making clear errors in its fact-finding, it said in a 98-page opinion issued Wednesday.
Judge Jeffrey Howard, who...
AstraZeneca Loses $12.9M AWP Appeal
To view the full article, take a free trial now.
